Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bacher

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Neurology|December 21, 2012
Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson diseaseDaniela Besong-Agbo, Elias Wolf, Frank Jessen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 19, 2018
Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adultsGene L Bowman, Loïc Dayon, Richard Kirkland, et al.
Molecular Medicine (Cambridge, Mass.)|March 5, 2010
The role of macrophage migration inhibitory factor in Alzheimer's diseaseMichael Bacher, Oliver Deuster, Bayan Aljabari, et al.
Oncogene|April 6, 2004
Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastomaYi Ren, Hiu Man Chan, Zhi Li, et al.
Atherosclerosis|December 9, 2004
Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaquesYao-Zhong Kong, Xiyong Yu, Jia-Ju Tang, et al.
Thrombosis and Haemostasis|May 10, 2023
Modulation of Extravascular Binding of Recombinant Factor IX Impacts the Duration of Efficacy in Mouse ModelsSteffi Knoll Machado, Hendrik Peil, Timo Kraushaar, et al.
Neuro-Degenerative Diseases|November 14, 2012
CNI-1493 attenuates neuroinflammation and dopaminergic neurodegeneration in the acute MPTP mouse model of Parkinson's diseaseCarmen Noelker, Vanessa Stuckenholz, Jens-Peter Reese, et al.
Cardiovascular Research|December 29, 2004
Evidence for vascular macrophage migration inhibitory factor in destabilization of human atherosclerotic plaquesYao-Zhong Kong, Xiao-Ru Huang, Xiaosen Ouyang, et al.
International Journal of Cancer|August 20, 2003
Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinomaYi Ren, Hong-Teng Tsui, Ronnie Tung-Ping Poon, et al.
The Journal of Experimental Medicine|June 25, 2008
CNI-1493 inhibits Abeta production, plaque formation, and cognitive deterioration in an animal model of Alzheimer's diseaseMichael Bacher, Richard Dodel, Bayan Aljabari, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Neurology|December 21, 2012
Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson diseaseDaniela Besong-Agbo, Elias Wolf, Frank Jessen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 19, 2018
Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adultsGene L Bowman, Loïc Dayon, Richard Kirkland, et al.
Molecular Medicine (Cambridge, Mass.)|March 5, 2010
The role of macrophage migration inhibitory factor in Alzheimer's diseaseMichael Bacher, Oliver Deuster, Bayan Aljabari, et al.
Oncogene|April 6, 2004
Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastomaYi Ren, Hiu Man Chan, Zhi Li, et al.
Atherosclerosis|December 9, 2004
Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaquesYao-Zhong Kong, Xiyong Yu, Jia-Ju Tang, et al.
Thrombosis and Haemostasis|May 10, 2023
Modulation of Extravascular Binding of Recombinant Factor IX Impacts the Duration of Efficacy in Mouse ModelsSteffi Knoll Machado, Hendrik Peil, Timo Kraushaar, et al.
Neuro-Degenerative Diseases|November 14, 2012
CNI-1493 attenuates neuroinflammation and dopaminergic neurodegeneration in the acute MPTP mouse model of Parkinson's diseaseCarmen Noelker, Vanessa Stuckenholz, Jens-Peter Reese, et al.
Cardiovascular Research|December 29, 2004
Evidence for vascular macrophage migration inhibitory factor in destabilization of human atherosclerotic plaquesYao-Zhong Kong, Xiao-Ru Huang, Xiaosen Ouyang, et al.
International Journal of Cancer|August 20, 2003
Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinomaYi Ren, Hong-Teng Tsui, Ronnie Tung-Ping Poon, et al.
The Journal of Experimental Medicine|June 25, 2008
CNI-1493 inhibits Abeta production, plaque formation, and cognitive deterioration in an animal model of Alzheimer's diseaseMichael Bacher, Richard Dodel, Bayan Aljabari, et al.
Pageof 6